Neurotransmitter metabolites in CSF: an external quality control scheme
- PMID: 12227459
- DOI: 10.1023/a:1016550324235
Neurotransmitter metabolites in CSF: an external quality control scheme
Abstract
We report an international external quality control scheme on neurotransmitter metabolites in cerebrospinal fluid (CSF). The neurotransmitter metabolites homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are analysed to diagnose inborn errors of neurotransmitter metabolism. HVA is the catabolite of dopamine; 5-HIAA is the catabolite of serotonin; and MHPG is the catabolite of noradrenaline. In the first phase, 12 laboratories from six countries participated in this special quality control scheme to define the present state of the art and achieve harmonization in analytical outcome and interpretation. In the second part, recoveries, dilutions and methods for sample preparation were compared. The results of 3 of 12 laboratories were excluded because of unacceptable intralaboratory coefficients of variations (CV) for HVA and/or 5-HIAA. The inter- and intralaboratory CVs, the linearity and the recovery were acceptable for the other laboratories for both parameters. Unacceptable differences in the reference ranges between laboratories, leading to differences in interpretation of the results, became obvious. There was a significant improvement of the interlaboratory CV for HVA after standardization with a calibrator. The reproducibility of MHPG measurement appeared to be adequately established in only two laboratories and recovery was low in all five measuring this metabolite. The quality control scheme is an invaluable tool for controlling the analytical outcome and providing support to laboratories to improve their quality.
Similar articles
-
Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?Med Biol. 1985;63(1):1-17. Med Biol. 1985. PMID: 2582215 Review.
-
Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.Anal Biochem. 1983 May;131(1):246-53. doi: 10.1016/0003-2697(83)90162-8. Anal Biochem. 1983. PMID: 6193730
-
Cerebrospinal fluid levels of monoamine metabolites in panic disorder.Psychiatry Res. 1991 Mar;36(3):243-51. doi: 10.1016/0165-1781(91)90023-i. Psychiatry Res. 1991. PMID: 1712114
-
The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.Eur Neuropsychopharmacol. 1994 Mar;4(1):1-6. doi: 10.1016/0924-977x(94)90308-5. Eur Neuropsychopharmacol. 1994. PMID: 7515737
-
Quantification of Monoamine Neurotransmitter Metabolites and Cofactors in Cerebrospinal Fluid: State-of-the-Art.Crit Rev Anal Chem. 2024;54(7):2007-2022. doi: 10.1080/10408347.2022.2151833. Epub 2022 Dec 7. Crit Rev Anal Chem. 2024. PMID: 36476251 Review.
Cited by
-
Monoamine neurotransmitter disorders--clinical advances and future perspectives.Nat Rev Neurol. 2015 Oct;11(10):567-84. doi: 10.1038/nrneurol.2015.172. Epub 2015 Sep 22. Nat Rev Neurol. 2015. PMID: 26392380 Review.
-
The Utility of CSF for the Diagnosis of Primary and Secondary Monoamine Neurotransmitter Deficiencies.EJIFCC. 2017 Mar 8;28(1):64-76. eCollection 2017 Mar. EJIFCC. 2017. PMID: 28439219 Free PMC article.
-
Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.Lancet Neurol. 2011 Jan;10(1):54-62. doi: 10.1016/S1474-4422(10)70269-6. Epub 2010 Nov 25. Lancet Neurol. 2011. PMID: 21112253 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources